(株)免疫生物研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証GRT | 医薬品 | 4570/E00986 | Immuno-Biological Laboratories Co.,Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2017/06/16 | 日証協 | 243,671株 | -3.68% | 4,600株 | +15% | 297,690株 | -5.04% | 2,500株 | -46.81% |
2017/06/09 | 日証協 | 252,971株 | +14.17% | 4,000株 | +400% | 313,490株 | +9.85% | 4,700株 | -44.05% |
2017/06/02 | 日証協 | 221,571株 | -19.54% | 800株 | -90.91% | 285,390株 | -13.01% | 8,400株 | +33.33% |
2017/05/26 | 日証協 | 275,371株 | -8.75% | 8,797株 | -84.51% | 328,090株 | -4.93% | 6,300株 | -41.67% |
2017/05/19 | 日証協 | 301,774株 | +17.48% | 56,800株 | +864.51% | 345,106株 | +1.83% | 10,800株 | +54% |
2017/05/12 | 日証協 | 256,874株 | -6.14% | 5,889株 | +741.29% | 338,913株 | -0.15% | 7,013株 | +289.61% |
2017/05/02 | 日証協 | 273,685株 | -1.23% | 700株 | -88.52% | 339,437株 | -0.35% | 1,800株 | +5.88% |
2017/04/28 | 日証協 | 277,085株 | -1.98% | 6,097株 | -85.45% | 340,637株 | -0.56% | 1,700株 | -91.67% |
2017/04/21 | 日証協 | 282,688株 | +23.07% | 41,897株 | -54.56% | 342,540株 | +9.95% | 20,400株 | -61.15% |
2017/04/14 | 日証協 | 229,691株 | +6.14% | 92,200株 | -44.09% | 311,543株 | +6.5% | 52,515株 | -22.33% |
2017/04/07 | 日証協 | 216,394株 | +68.63% | 164,894株 | +154.52% | 292,521株 | +35.9% | 67,613株 | +23.45% |
2017/03/31 | 日証協 | 128,324株 | +35.92% | 64,786株 | +206.88% | 215,249株 | +0.43% | 54,771株 | +360.26% |
2017/03/24 | 日証協 | 94,411株 | -1.66% | 21,111株 | -29.16% | 214,338株 | -2.14% | 11,900株 | -59.39% |
2017/03/17 | 日証協 | 96,000株 | +22.61% | 29,800株 | +105.52% | 219,027株 | -5.73% | 29,301株 | -70.14% |
2017/03/10 | 日証協 | 78,300株 | 0% | 14,500株 | 0% | 232,338株 | +1.35% | 98,120株 | +9999.99% |
2017/03/03 | 日証協 | 78,300株 | -3.69% | 0株 | -100% | 229,238株 | -1.25% | 500株 | -78.54% |
2017/02/24 | 日証協 | 81,300株 | +0.74% | 600株 | 0% | 232,138株 | +0.62% | 2,330株 | +133% |
2017/02/17 | 日証協 | 80,700株 | -2.65% | 0株 | 0% | 230,708株 | +15.39% | 1,000株 | -97.04% |
2017/02/10 | 日証協 | 82,900株 | -0.48% | 0株 | -100% | 199,944株 | -8.55% | 33,800株 | +604.17% |
※株式分割は考慮していませんのでご注意ください。